80483-13-2

Basic information

• Product Name: ACETOBROMOFUCOSE
• CAS NO: 80483-13-2
• Molecular Formula: C₁₂H₁₇BrO₇
• Molecular Weight: 0
• Mol File: 80483-13-2.mol
• Article Data: 35

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ACETOBROMOFUCOSE(CAS DataBase Reference)
• NIST Chemistry Reference: ACETOBROMOFUCOSE(80483-13-2)
• EPA Substance Registry System: ACETOBROMOFUCOSE(80483-13-2)

Safety Data

• Hazardous Substances Data: 80483-13-2(Hazardous Substances Data)

Upstream product

• 506-96-7 Acetyl bromide 
• 73-34-7 6-deoxy-L-galactose 
• 73-34-7 D-Fucose 
• 30571-58-5 L-fucose tetraacetate 
• 7404-35-5 1,2,3,4-tetra-O-acetyl-L-fucopyranose 
• 73-34-7 6-deoxy-L-talopyranoe 
• 7404-35-5 Acetic acid (3R,4R,5R,6S)-2,3,5-triacetoxy-6-methyl-tetrahydro-pyran-4-yl ester 
• 643-17-4 α-D-rhamnopyranose 
• 1187858-70-3 1,2,3,4-tetra-O-acetyl-L-rhamnopyranose 
• 64-19-7 acetic acid 
• 4026-27-1 1,2:3,4-di-O-isopropylidene-α-D-fucopyranose 
• 28161-52-6 (2R,3R,4S,5R,6R)-6-Methyl-tetrahydro-pyran-2,3,4,5-tetraol 
• 34371-41-0 1,2,3,4-tetra-O-acetyl-6-deoxy-β-D-galactopyranose 
• 108-24-7 acetic anhydride 

Downstream Products

• 88819-15-2 benzyl 3,4-di-O-benzyl-6-deoxy-2-O-(α-L-rhamnopyranosyl)-α-L-talopyranoside 
• 3359-36-2 benzyl 2,3,4-tri-O-acetyl-α-L-rhamnopyranoside 
• 180471-90-3 8-methoxycarbonyloctyl 2,3,4-tri-O-acetyl-6-deoxy-β-D-galactopyranosyl-(1->3)-2-acetamido-4,6-O-benzylidene-2-deoxy-β-D-glucopyranoside 
• 482648-35-1 phenylmethyl 2,3,4-triacetyl-β-D-fucopyranoside 
• 69558-02-7 Ethyl 2,3,4-tri-O-acetyl-1-thio-α/β-L-fucopyranoside 
• 211801-54-6 p-methylphenyl 2,3,4-tri-O-benzyl-1-thio-β-L-fucopyranoside 
• 245450-72-0 hept-6-enoic acid 4,5-bis-benzyloxy-2-{7-benzyloxy-2-phenyl-6-[2,2,4-trimethyl-6-(1-pentyl-hex-5-enyloxy)-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yloxy]-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy}-6-methyl-tetrahydro-pyran-3-yl ester 
• 245450-69-5 hept-6-enoic acid 4,5-bis-benzyloxy-2-{8-benzyloxy-2-phenyl-6-[2,2,4-trimethyl-6-(1-pentyl-hex-5-enyloxy)-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yloxy]-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yloxy}-6-methyl-tetrahydro-pyran-3-yl ester 
• 245450-68-4 acetic acid 4,5-bis-benzyloxy-2-{8-benzyloxy-2-phenyl-6-[2,2,4-trimethyl-6-(1-pentyl-hex-5-enyloxy)-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yloxy]-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yloxy}-6-methyl-tetrahydro-pyran-3-yl ester 
• 245450-71-9 acetic acid 4,5-bis-benzyloxy-2-{7-benzyloxy-2-phenyl-6-[2,2,4-trimethyl-6-(1-pentyl-hex-5-enyloxy)-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yloxy]-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy}-6-methyl-tetrahydro-pyran-3-yl ester 
• 871919-79-8 Undec-10-enoic acid (2R,4aR,6S,7R,8R,8aR)-7-hydroxy-2-phenyl-6-[(3aS,4R,6R,7R,7aS)-2,2,4-trimethyl-6-((S)-1-pentyl-hex-5-enyloxy)-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yloxy]-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yl ester 
• 245450-77-5 Hept-6-enoic acid (2S,3R,4R,5S,6S)-4,5-bis-benzyloxy-6-methyl-2-[(3aS,4R,6R,7R,7aS)-2,2,4-trimethyl-6-((S)-1-pentyl-hex-5-enyloxy)-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yloxy]-tetrahydro-pyran-3-yl ester 
• 245450-60-6 Pent-4-enoic acid (2R,4aR,6S,7R,8R,8aR)-7-hydroxy-2-phenyl-6-[(3aS,4R,6R,7R,7aS)-2,2,4-trimethyl-6-((S)-1-pentyl-hex-5-enyloxy)-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yloxy]-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yl ester 

Relevant articles and documents

Non-isosteric C-glycosyl analogues of natural nucleotide diphosphate sugars as glycosyltransferase inhibitors

A series of C-glycosyl ethylphosphonophosphate analogues of UDP-Glc, UDP-Gal, UDP-GlcNAc and GDP-Fuc were synthesized from the corresponding C-glycosyl ethylphosphonic acids. Analogues were obtained as α-anomers through either diastereoselective photo-induced radical addition of glycosyl bromides (d-Glc, d-Gal and l-Fuc) to diethyl vinylphosphonate, or a multi-step sequence (d-GlcNAc), with subsequent coupling with morpholidate-activated nucleotide monophosphates. The in vitro inhibitory activity of UDP-Gal, GDP-Fuc and UDP-GlcNAc analogues towards glycosyltransferases (β-1,4-GalT, FUT3 and LgtA) was evaluated through a competition fluorescence assay and IC50 values of 40 μM, 2 mM and 3.5 mM were obtained, respectively.

Synthesis and biological evaluation of 3β-O-neoglycosides of caudatin and its analogues as potential anticancer agents

In order to study the structure–activity relationship (SAR) of C21-steroidal glycosides toward human cancer cell lines and explore more potential anticancer agents, a series of 3β-O-neoglycosides of caudatin and its analogues were synthesized. The results revealed that most of peracetylated 3β-O-monoglycosides demonstrated moderate to significant antiproliferative activities against four human cancer cell lines (MCF-7, HCT-116, HeLa, and HepG2). Among them, 3β-O-(2,3,4-tri-O-acetyl-β-L-glucopyranosyl)-caudatin (2k) exhibited the highest antiproliferative activity aganist HepG2 cells with an IC50 value of 3.11 μM. Mechanical studies showed that compound 2k induced both apoptosis and cell cycle arrest at S phase in a dose dependent manner. Overall, these present findings suggested that glycosylation is a promising scaffold to improve anticancer activity for naturally occurring C21-steroidal aglycones, and compound 2k represents a potential anticancer agent deserved further investigation.

Total Synthesis of Tri-, Hexa- and Heptasaccharidic Substructures of the O-Polysaccharide of Providencia rustigianii O34

A general and efficient strategy for synthesis of tri-, hexa- and heptasaccharidic substructures of the lipopolysaccharide of Providencia rustigianii O34 is described. For the heptasaccharide seven different building blocks were employed. Special features of the structures are an α-linked galactosamine and the two embedded α-fucose units, which are either branched at positions-3 and -4 or further linked at their 2-position. Convergent strategies focused on [4+3], [3+4], and [4+2+1] couplings. Whereas the [4+3] and [3+4] coupling strategies failed the [4+2+1] strategy was successful. As monosaccharidic building blocks trichloroacetimidates and phosphates were employed. Global deprotection of the fully protected structures was achieved by Birch reaction.

Neuroprotective activity of different monosaccharide-modified gastrodin analogs

Gastrodin is a very important and well-known bioactive glycoside compound in Chinese medicine. It is also known as a drug with neuroprotective function. Here, a practical diversified synthesis of a series of gastrodin analogs was reported, which involved four-step procedures consisting of bromination, oxidation, etherification, and reduction. Various gastrodin analogs were obtained in good yields. The compound 4c in this study has a good neuroprotective function: it can significantly downregulate tumor necrosis factor-α and inducible nitric oxide synthase protein levels. The results of this study can provide a research basis for the development of neuroprotective drugs.